Tag: Hepatitis
Subcirrhotic Liver Stiffness Cuts HCC Risk in Hepatitis B
Achievement of subcirrhotic range of liver stiffness with antiviral therapy reduces HCC risk
Improved Glycemic Control With Eradication of Hepatitis C
Improved glycemic control, reduced antidiabetic medication use with sustained virologic response
HCC Drops Beyond Five Years of Entecavir/Tenofovir Tx for Hep B
Older age, lower platelets at baseline and year five, liver stiffness ≥12 kPa linked to HCC development
High HCV Cure Rates in HIV Coinfection Cases at Urban Clinic
Sustained virologic response rate of 97 percent, with no variation by race in predominantly black cohort
Three-Drug Combo Pill Nearly 100 Percent Effective in Curing Hep C
Pill (sofosbuvir, velpatasvir, voxilaprevir) is for patients who have failed with direct-acting antivirals
CDC: Hep C Infections Among Pregnant Women Increasing
Rural counties seem hardest hit and rates mirror opioid epidemic
Transplanting HCV+ Kidneys Into HCV− Recipients Feasible
Doctors say they can clear hepatitis C in organ recipients, perhaps shortening transplant waits
CDC: Steep Rise in New HCV Infections Over Last Five Years
Many stemmed from rising use of injected drugs linked to the current opioid epidemic, officials say
HCV Infection Increasing in Reproductive-Aged Women
Doubling in number of women with past or present HCV infection in NNDSS from 2006 to 2014
HBV Reactivation Is Concern With DAA Tx in HBV-HCV Coinfection
29 cases of HBV reactivation reported in patients with coinfection receiving direct-acting antivirals
